Understanding the New Washington State Pain Medication and Opioid Rules


The state of Washington has recently adopted new rules, or “standards of practice,” relating to pain management that apply to all physicians within the state. These new rules are in response to the rising statistics regarding prescription drug abuse involving opioids, the costs of such medications, a belief that the lack of guidance among physicians is contributing to the drug abuse problem in our society, and the belief that there should be a more coherent approach to pain medicine in the non-cancer, non-palliative setting.

Each governing medical board or commission was delegated to create its own rules. The new rules applying to primary care physicians are codified in WAC 246-919-850 through 246-919-863 and are scheduled to become effective January 2, 20121. Violation of these rules may lead to charges by the Medical Quality Assurance Commission (“MQAC”) for deviation from the standard of care and unprofessional conduct. The rules should be closely read, and protocols and procedures implemented in clinical practice to ensure their observance. It is also important to document instances where the provider elects to deviate from these rules. While the rules state in their preamble that they are not meant to be “inflexible,” and that there may be exceptions to the rules based upon “sound clinical judgment,” there is no doubt that the rules set forth a standard of care meant to be followed. (WAC 246-919-850)

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Lane Powell PC | Attorney Advertising

Written by:


Lane Powell PC on:

Popular Topics
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.